招股说明书补充 | 根据424(b)(2)条款提交 | |
(根据2024年9月19日的招股说明书) | 注册编号333-282028 |
SRM 娱乐股份有限公司。
1,711,477 普通股股份
我们正在向合格投资者出售1,711,477股普通股,每股面值为0.0001美元,以0.61美元的发行价出售,根据本招股说明书和随附的基本招股说明书。普通股直接向合格投资者提供,没有放置代理或承销商。我们在本次发行中不支付放置代理费用或承销折扣。
普通股份的销售将根据一份《证券购买协议》进行,我们与四家投资者签署了这份协议(每份为“证券购买协议”)。三份证券购买协议分别于2024年10月18日订立,其中三份与三家投资者签订,而一份证券购买协议则于2024年10月19日订立,与一家投资者签订。
我们的普通股在纳斯达克资本市场上市,交易标的为“SRM”。2024年10月18日,我们的普通股在纳斯达克资本市场的最后报价为每股0.71美元。
每股 | 总费用(1) | |||||||
公开发行价格 | $ | 0.61 | $ | 1,044,000 |
1我们没有利用配售代理或承销商。
投资 投资我们的证券涉及风险。请参阅本招股说明书第4页和适用招股补充说明书中任何类似章节中与您投资我们的证券前应考虑的因素相关的内容。 “风险因素” 在该招股说明书附录的第S-5页 以及附属基础招股说明书的第4页,并且在已纳入该招股说明书附录及附属基础招股说明书的文件中的类似标题下。
根据本招股说明书补充的日期,我们未持有的非关联方持有的未结算普通股的总市值为6,883,980美元,基于12,165,000股未结算普通股,其中6,522,393股由关联方持有,每股价格为1.22美元,基于2024年9月5日我公司普通股的收盘价。根据S-3表格的I.b.6通用指示,我们将不会在公开首次发行中出售价值超过我们公开流通市值三分之一的普通股,在我们的公开流通市值低于7,500万美元的情况下,每12个月。在结束并包括招股说明书日期的之前的12个日历月期间内,我们根据I.b.6通用指示未提供任何证券。
证券交易委员会或任何州证券委员会均未批准或不批准这些证券,也未就本招股说明书的充分性或准确性做出评价。任何反说的陈述都是犯罪行为。
本拓展说明书补充的日期为2024年10月21日。
目录
招股书补充资料
关于本招股说明书补充文件 | S-1 |
在哪里可以找到更多信息;以引用方式纳入 | S-1 |
招股说明书补充摘要 | S-3 |
报价摘要 | S-4 |
风险因素 | S-5 |
关于前瞻性陈述的特别通知 | S-5 |
所得款项的使用 | S-6 |
我们普通股的市场价格 | S-6 |
股息政策 | S-6 |
分配计划 | S-6 |
我们提供的证券的描述 | S-6 |
法律事务 | S-6 |
专家们 | S-6 |
招股书
S-i |
本招股说明书补充及随附的基本招股说明书属于我们向美国证券交易所提交的注册申报文件的一部分,采用“货架”注册程序。该文件分为两部分。第一部分是本招股说明书补充,描述了本次发行的具体条款,并补充和更新了随附的基本招股说明书及参考文件中的信息。第二部分是随附的基本招股说明书,提供更多一般信息。通常情况下,我们提到本招股说明书时,指的是本文件的两个部分的结合体。在本招股说明书补充和随附的基本招股说明书或在本招股说明书补充之前提交的任何参考文件中包含的信息存在冲突的情况下,您应依赖于本招股说明书补充中的信息;但如果这些文件中的任何一份文件的声明与另一份具有较晚日期的文件中的声明存在不一致情况,例如,随附的基本招股说明书中以引用方式纳入的文件,较晚日期的文件中的声明修改或取代较早的声明。
我们还指出,我们在任何文件中所作的陈述,保证和契约,该文件作为引用纳入这里所述的任何文件中,仅是为了使这些协议的各方,包括某些情况下用于在这些协议的各方之间分配风险,而对您并不构成保证、担保或协议。此外,这些保证、保证或协议只有在作出时准确无误时才是准确的。因此,不应将这些陈述、保证和契约作为准确表达我们事务当前状态的依据。
您只应该依赖于本补充招股说明书或随附的基础招股说明书中包含的信息或者在此处引用的信息。我们未授权任何人向您提供不同的信息。本补充招股说明书或随附的基础招股说明书中包含的信息,或者在此处或其中引用的信息仅截至各自的日期为准,不论本招股说明书补充内容和随附的基础招股说明书何时交付,或者我们普通股的任何销售。您在做出投资决定时应该阅读并考虑本招股说明书补充和随附的基础招股说明书中包含的所有信息,包括在此引用和其中引用的文件。您还应该阅读并考虑我们在“您可以查阅更多信息”和“引用某些信息”章节中向您提及的文件中的信息,分别在本招股说明书补充和随附的基础招股说明书中。
我们正在提供出售,并寻求要约购买,本招股说明书补充中提供的证券,仅限于允许进行要约和销售的司法管辖区。本招股说明书补充及随附的基础招股说明书的分发,以及在某些司法管辖区提供本招股说明书补充中提供的证券,可能受到法律限制。在美国以外的个人如获得本招股说明书补充及随附的基础招股说明书,必须就与普通股的发行以及在美国以外分发本招股说明书补充及随附的基础招股说明书相关的任何限制情况进行了解,并遵守。本招股说明书补充及随附的基础招股说明书不构成,并且不得用于与本招股说明书补充中提供的证券有关的出售要约或任何人在任何不允许此类人进行此类要约或邀约的司法管辖区内使用。
在本招股说明书中,当我们提到“SRm”,“我们”,“我们的”,“我们”和“公司”时,指的是SRm娱乐公司及其合并子公司,除非另有说明。当我们提到“您”时,指的是适用系列证券的持有人。
更多信息位于哪里 CAN 所有板块可以查找更多信息;通过引用其他文档综合。
可用信息
SEC维护着一个网站,其中包含了报告、代理和信息声明以及其他关于像我们一样通过电子方式向SEC提交文件的发行人的信息。该网站的地址是 http://www.sec.gov.
我们的网址是https://srmentertainment.com/。然而,我们网站上的信息不属于,也不应被视为,本招股说明书的一部分。
本招股说明书及任何招股补充文件均属于我们向美国证券交易委员会(SEC)提交的注册声明的一部分,不包含注册声明中的所有信息。完整的注册声明可从SEC或我们处获得,具体步骤详见下文。建议书中说明证券条款的文件形式是或可能是附表,文件中对这些文件的陈述均为摘要,每一陈述都要以其所涉及的文件作为参考来适用。详细事项的更完整描述,请参阅实际文件。您可以通过SEC的网站查看注册声明的副本,网址如上所示。
S-1 |
引用
SEC的规定允许我们"通过引用"的方式将信息纳入本说明书补充,这意味着我们可以通过指向与SEC分开提交的另一份文件向您披露重要信息。 被纳入参考的信息被视为本说明书补充的一部分,我们向SEC提交的后续信息将自动更新和取代该信息。 任何被纳入参考的之前提交的文件中包含的声明将被视为已被修改或取代,以便本说明书补充中的声明修改或取代那个声明。
我们通过引用以下列出的文件以及我们在证券交易法案的第13(a)、13(c)、14或15(d)条项下向SEC提交的任何未来申请,在本招股书中称为“交易所法案”,在本招股书的日期和本招股书所述证券的发行终止之间,除此之外,我们不会引用被SEC未视为“备案”的文件或部分文件,包括根据8-k表第2.02或7.01项提供的信息或根据8-k表第9.01项提供的相关展示文件。
本募集说明书具有以下曾经与SEC提交的文件的引用内容:
● | 我们 关于2023年12月31日报告已在2024年3月29日向美国证券交易委员会提交; 10-K表格 for the year ended December 31, 2023, filed with the SEC on April 1, 2024; |
● | 我们截至2024年3月31日的第10-Q表季度报告已在SEC提交 2024年5月10日 并截至2024年6月30日的第10-Q表季度报告已在SEC提交 2024年8月12日 and; |
● | 我们的当前报告书表格8-k已经提交给SEC 2024年9月6日和2024年9月13日. |
● | 我们普通股票(每股面值$0.0001)的描述包含在我们的注册文件中。 8-A表格,在2023年8月2日提交给美国证券交易委员会(SEC),并由“根据1934年证券交易法第12节注册的注册人证券描述”进行更新,提交为 展品4.3 ,至2023年12月31日结束的财政年度的年度报告10-K表格中,并为更新此描述而提交的任何修订或报告。 |
您可通过书面或电话方式向以下地址请求免费获取任何被引入本招股说明书中的文件的副本(除非这些文件的附件被明确地引入这些文件):
1061 E. Indiantown Rd., Ste. 110
FL 33477 朱庇特市
电话: 407-230-8100
展览品将不会发送,除非这些展览项目已经明确纳入了本招股补充资料中。
S-2 |
以下信息仅为其他文档中或通过引用纳入的更详细信息的摘要,应与本《招股说明书补充》和随附的基本招股说明书中包含的或纳入引用的信息一起阅读。本摘要突出了关于我们和本次发行的选定信息。本摘要可能未包含所有对您可能重要的信息。在决定投资于我们的证券之前,您应仔细阅读本《招股说明书补充》和随附的基本招股说明书中包含的或纳入引用的所有信息,包括本《招股说明书补充》中的“风险因素”栏下列出的信息以及通过引用纳入的文件,这些文件在本《招股说明书补充》的“您可以获取更多信息的地方;通过引用纳入”部分中有描述。除非另有说明或上下文要求,本招股说明书包括SRm娱乐公司(SRm Entertainment, Inc.)及其全资子公司的账目,统称为“我们”、“我司”、“我们的”或“SRM”或“公司”。
公司
常规 概述
SRM 娱乐股份有限公司(“SRm Inc”)是一家内华达州公司,成立于2022年4月22日。SRm. 娱乐有限公司(“SRm Ltd”),是一家1981年1月23日成立于中国香港、现为中国人民共和国特别行政区的有限公司,曾为木星健康公司所有。2023年8月14日,SRm Inc收购了SRm Ltd。 SRm Inc对SRm Ltd的收购已作为反向收购进行核算(见下文的报表编制基础)。 合并的SRm Inc和SRm Ltd统称为公司或SRm。
2022年12月9日,我们与Jupiter Wellness, Inc.(“Jupiter”)达成了一项股票交易协议(“交易协议”),以规范我们与Jupiter业务的分离。2023年5月26日,我们修订并重新签署了交易协议(“股份交易”),以包含关于分配和与Jupiter业务分离的额外信息。按照与Jupiter签订的股份交易,分离于2023年8月14日关闭。根据股份交换协议,于2023年5月31日,我们向Jupiter发行了6,500,000股普通股(占我们已发行的普通股的79.3%),以换取SRm Ltd公司的2股普通股(代表SRm Ltd已发行和流通的所有普通股)。自2023年9月15日起,Jupiter更名为Safety Shot, Inc.(“Safety Shot”)。截至2024年10月15日,Safety Shot拥有我们普通股的28.2%。
表述基础
本招股说明书附表中引入的财务报表符合美国通用会计准则(“GAAP”)和美国证券交易委员会(“SEC”)规定。SRm Ltd和SRm Inc的收购发生在2023年8月14日。该财务报表是使用反向收购会计准则编制的,因此,在法律目的下,SRm Inc是收购公司,在GAAP会计中,SRm Ltd是收购公司。因此,这些财务报表使用SRm Ltd的历史财务报表呈现。
按照我们所处的风险和不确定性的假设,结果和在本招股书或在任何文档中引用的前瞻性陈述中讨论的事件可能不会发生。投资者应谨慎对待这些前瞻性陈述,它们仅在本招股书或在文档中通过引用作为参考,其仅在本招股书或在文档中通过引用作为参考的文件的日期发表时存在。我们没有任何义务,并明确声明不承担任何义务,更新或更改任何前瞻性陈述,无论是基于新信息、未来事件或其他原因。我们或代表我们行事的任何人作出的所有后续前瞻性陈述,都受到本节中所包含或所提到的警示性声明的明确限制。
该公司是一家备受信赖的玩具和纪念品设计师和开发商,产品销售至全球最大的主题公园和娱乐场所。
我们的业务建立在几乎每个人都是某件事的粉丝以及普普文化的演进正在为粉丝忠诚度带来越来越多的机会的原则之上。我们创造了奇趣、有趣和独特的产品,让粉丝们能够表达他们对自己喜欢的“某件事”的喜爱,无论是电影、电视节目、喜欢的名人还是喜欢的餐厅。我们将独特的设计和审美理念融入到各种产品类别中,包括公仔、毛绒玩具、配饰、服装和家居用品。凭借我们独特的风格、对普普文化的专业知识、广泛的产品分销和极具可及性的价格,我们已经为我们的产品建立了一个充满激情的追随者群,这支持着我们的增长。我们相信我们位于普普文化的中心——内容提供商看重我们的广泛零售客户网络,零售商看重我们的普普文化产品组合和普普文化洞察,消费者看重我们独特的、风格化的产品以及它们所代表的内容。
普普文化渗透到现代生活中,几乎每个人都是某种迷。如今,有更多优质内容可供选择,科技创新使内容随时随地可获取。结果是,普普文化迷的广度和深度类似,并在许多情况下超过了仅与体育相关联的迷的类型。家庭、工作或与朋友的日常互动越来越受普普文化的影响。
我们在普普文化领域与关键利益相关方进行了战略投资。内容提供商重视我们庞大的零售客户网络,零售商重视我们的普普文化产品、普普文化洞察力以及带动消费者流量的能力。消费者重视我们独特、风格化的产品,他们始终是我们工作的中心。
S-3 |
2024年9月3日,公司与Suretone Entertainment,Inc.(以下简称“Suretone”或“卖方”)签订了一份资产购买协议(“资产购买协议”),根据该协议,公司同意从卖方收购与电影《The Kid》(由文森特·德·奥诺弗里奥执导)相关的某些资产,交易的总购买价格为300万美元(“购买价格”)。Suretone的所有者和首席执行官乔丹·舒尔(Jordan Schur)是Safety Shot的董事会成员兼总裁。在交易发生之前,Safety Shot持有公司普通股的34.27%。
就已收购资产而言,买方于2024年9月3日以如下方式支付购买价格:(i)支付现金250,000美元;(ii)发行1,500,000股公司普通股股票,每股面值0.0001美元(按0.8333美元/股计价);以及(iii)发行1,500,000美元的有担保的票据(“有担保票据”)。
内容提供者: 我们与许多知名内容提供商建立了授权关系,我们的产品出现在华特迪士尼乐园和度假区、环球影城、海洋世界、雪松娱乐、赫申德家族娱乐和梅林娱乐等场所。我们目前与蓝精灵、ICEE公司和Zoonicorn LLC有许可协议,基于每个角色,我们可以创建多个产品。内容提供商信任我们来设计、创造和制造与其知识产权相关的独特、风格化的延伸产品,通过持续的参与促使其内容与消费者的关系保持活跃,从而最大化其内容的生命周期价值。
消费者粉丝们越来越希望找到表达他们对最喜爱的普普文化内容的喜爱,并与之互动的方式。随着时间的推移,我们的消费者中许多人从偶尔购买者发展为更频繁购买者,我们将他们归类为热衷者或收藏家。我们创造创新产品,以吸引各种各样的粉丝,覆盖不同的消费人群-男性、女性、男孩和女孩,而不只是单一的、狭窄的人群。我们目前提供各种各样畅销的产品。我们的产品通常定价在$2.50 到 $50.00 之间,这使我们多样化的消费者群体能够经常且冲动地表达他们的狂热之情。我们继续推出旨在促进不同价格点和风格的粉丝参与的创新产品。
我们已经开发出一种灵活且低固定成本的生产模式。我们管理团队的实力和与内容提供商、零售商以及第三方制造商的关系,使我们能够从产品概念转变为新产品。因此,我们可以灵活地管理我们的业务,平衡当前内容发布和潮流的普普文化以及基于经典电影(如哈利波特或星球大战)的不朽内容。这使我们能够在减少对个别内容发布的依赖的同时实现显著增长。
本摘要突出了有关本募集及本招股说明书补充中的某些信息和其他地方包含的精选信息。 本摘要并非完整,也不含您在决定是否投资证券之前应考虑的所有信息。 为了更全面地了解我们公司和本募集,我们鼓励您仔细阅读并考虑本招股说明书和随附的基础招股说明书中更详细的信息,包括本招股说明书和随附的基础招股说明书中引用的信息以及本招股说明书中“风险因素”标题下S-5页和随附基础招股说明书第4页中提及的信息,以及纳入本招股说明书和随附基础招股说明书的文件。
处置 | SRM 娱乐,公司。 | |
我们发行的普通股 | 1,711,477股 | |
本次发行前的普通股(1) | 12,165,000股 | |
本次发行后将会有的普通股(1) | 13,876,477股 | |
普通 股票交易标的 | 我们 的普通股票在纳斯达克资本市场交易,交易标的为“SRM”。 | |
所得款项的用途 | 我们 打算利用此次发行的净收益用于营运资金和一般公司用途。请参阅“资金用途”。 | |
风险因素。 | 此 投资涉及高度风险。请参阅本招股说明书补充的“风险因素”和其他资料,从第S-5页开始以及附注的基础招股说明书,从第4页开始讨论您在决定投资我们的普通股股份之前应当慎重考虑的某些因素。 |
(1) | 普通股股份总数是基于截至2024年10月21日已发行和流通的普通股份数量,并不包括以下情况: |
● | 1,085,000 股普通股,可行使未行使的股票期权,带权平均行权价为1.23美元 每股; | |
● | 415,000 股普通股,公司2023年股权激励计划的未来发行储备。 |
S-4 |
任何根据本招股说明书及相关补充招股说明书所提供的证券投资都存在风险。在购买这些证券之前,您应仔细考虑参考我们最近的年度报告(10-K表格)和随后的季度报告(10-Q表格)或最新的当前报告(8-K表格),以及本招股说明书中包含或参考的其他信息,并结合我们根据交易所法案进行的随后的文件更新的风险因素和其他信息。任何这些风险的发生可能导致您失去您在所提供证券的投资中的全部或部分。
与本次发行有关的风险
我们可能会以您或其他股东可能不赞成的方式分配本次发行的净收益。
我们目前打算使用本次发行的净收益(如果有的话)用于营运资金和一般企业用途,这可能包括资本支出、融资可能的收购或业务扩张。本次发行的净收益的预期使用代表我们基于当前计划和业务条件的意图。由于影响我们使用本次发行收益的因素的数量和变异性较大,最终使用可能与当前意图的使用有较大差异。因此,我们管理层将对本次发行的净收益分配保留广泛的自由裁量权,并可能以并不一定能改善我们运营业绩或增强我们普通股价值的方式使用这些收益。请参阅“资金用途”。
本次发行中我们普通股的销售,或者有可能出现这种情况的认知,都有可能导致我们普通股的市场价格下跌。
我们可能不时发行和卖出普通股,总收益金额高达$1,044,000,与本次发行有关。不时发行和出售这些新的普通股,或者我们有能力在本次发行中发行这些新的普通股,可能会导致我们的普通股市场价格下跌。
我们可能出售更多普通股来资助经营,这些销售可能在本次发行后或发行期间进行,这将导致股东持股比例稀释。
为了筹集额外所需的资金以支持我们的业务,我们可能出售更多普通股股票,这将导致对所有股东的稀释,可能不利于我们的业务。请参阅“稀释”。特别是在任何时候,包括在本次发行期间,我们可能会出售额外的普通股股票,除本次发行外,出售的数量可能对我们具有重大影响,该数量可能相等或超过本次发行的规模,包括但不限于通过承销公开发行、私下协商交易、大宗交易或以上任何组合的方式,在某些情况下需要经代理人同意。我们无法保证我们能够以每股价格出售股票或其他证券,该价格等于或高于本次发行中投资者支付的每股价格,未来购买股票或其他证券的投资者可能拥有优于现有股东的权利。我们出售额外普通股或其他未来交易中可转换为或可交换为我们的普通股的证券的每股价格可能高于或低于本次发行中的每股价格。
本招股说明书包含涉及风险和不确定性的前瞻性陈述,主要在“风险因素”部分。除本招股说明书中包含的历史事实陈述之外,包括关于未来事件、我们未来的财务表现、业务策略和管理层对未来经营目标的计划,均属于前瞻性陈述。我们已尽力通过术语,“预计”,“相信”,“能”,“继续”,“可能”,“估计”,“预测”,“计划”,“潜力”,“预测”,“应”,或这些术语的否定或其他可比术语等方式,识别前瞻性陈述。尽管我们不会在没有合理依据的情况下进行前瞻性陈述,但我们无法保证其准确性。这些陈述仅为预测,并涉及已知和未知的风险、不确定性和其他因素,包括本招股说明书中“风险因素”部分或其他地方概述的风险,可能导致我们或我们所在行业的实际结果、活动水平、表现或成就,超出或低于这些前瞻性陈述的预期表述或暗示。
S-5 |
良好的前瞻性陈述不应被视为对未来业绩或结果的保证,并不一定准确地表示该业绩或结果将在何时达到。前瞻性陈述基于其制作时可获得的信息和/或管理层在那个时刻对未来事件的真实信念,并且受到可能导致实际业绩或结果与前瞻性陈述中所表达或暗示的有所不同的风险和不确定性的影响。
前瞻性陈述仅在其发布之日有效。您不应该对任何前瞻性陈述过分依赖。我们对更新前瞻性陈述不承担任何义务,以反映实际结果、假设变化或其他影响前瞻性信息的因素的变化,除非适用证券法律要求。如果我们更新一个或多个前瞻性陈述,不应该推断出我们将对这些或其他前瞻性陈述进行额外更新。
我们目前打算将本次募资的净收益(如果有的话)用于营运资金和一般公司用途。
我们实际支出的时间和金额将基于许多因素,包括业务运营现金流和业务增长预期。就本招股说明书日期而言,我们无法确定对于本次发行所得款项的所有具体用途。因此,我们管理层将在对本次发行所得款项的时间和用途方面拥有广泛的自主权。在最终使用这些款项之前,我们打算将其投资于开空、投资级、利息-bearing工具。
我们的普通股目前在纳斯达克资本市场上市,交易标的为“SRM”。截至2024年10月18日,我们的普通股最后报价为0.71美元。
持有人
截至2024年10月14日,我们有29名注册持有我们普通股的股东。由于我们的某些普通股由经纪人和其他机构代表股东持有,上述持有我们普通股的股东人数并不代表我们普通股受益人的数量。
我们从未宣布或支付我们的股本股息。我们目前打算保留未来的盈利(如果有的话)用于我们的业务,因此在可预见的未来不打算支付现金股息。未来的分红派息(如果有的话)将由我们的董事会酌情决定,考虑各种因素,包括我们的财务状况、运营结果、目前和预期的现金需求以及扩张计划。
我们从未宣布或支付过现金分红给我们的股本。我们当前打算留存未来的收益(如果有的话),用于我们的业务,因此在可预见的将来不打算支付现金分红。未来(如果有的话)的分红支付将由我们的董事会自行决定,考虑到各种因素,包括我们的财务状况、运营结果、当前和预期的现金需求以及扩张计划。
我们正在提供1,711,477股普通股,募集总收益约为$1,044,000,扣除我们支付的法律费用和发行支出前。
我们已与四名合格投资者签订了四份证券购买协议,与本次发行有关。本增补说明书所提供的普通股的发行价是根据投资者与我们之间的公平交易谈判确定的。
我们向投资者发行和卖出普通股份的义务受限于我们与投资者之间所订立的证券购买协议中规定的条件。投资者购买普通股份的义务受限于证券购买协议中规定的条件。
我们将在收到投资者购买股票所需基金后,电子交付发行的普通股给投资者。我们预计将于2024年10月22日前后将证券交付给投资者,视习惯交割条件满足而定。
在此次发行中,我们以每股0.61美元的公开发行价最多发行1,711,477股普通股。
我们普通股的主要条款和规定在随附的基本招股说明书第5页以及标题为“股本说明”开始描述。
转让代理
公司的过户代理是ClearTrust Transfer,LLC,地址为16540 Pointe Village Drive,Suite 210,Lutz,FL 33558,电话号码为(813) 235-4490。
本次所提供的普通股的有效性将由新泽西州伍德布里奇的Lucosky Brookman LLP律师事务所负责审查。
截至2023年12月31日和2022年,我们的综合资产负债表,以及相关的综合损益表、股东权益(赤字)和现金流量表,已经由独立注册的会计师事务所M&k CPAS, PLLC进行了审计,其报告已作为参考并依赖于该公司的会计和审计专家意见。
S-6 |
招股说明书
SRM 娱乐股份有限公司。
$25,000,000
普通股
优先股
债务证券
权证
权利
单位
我们可能会在一个或多个发行中,不时地提供并卖出上述证券的累计金额最高为2500万美元。 本招股说明书为您提供了对该证券的概括描述。
每次我们发行和销售证券时,我们都将提供本招股说明书的补充资料,其中包含有关发行和证券的金额、价格和条款的具体信息。该补充资料可能还会在本招股说明书中添加、更新或更改相关信息。在投资我们的任何证券之前,您应该仔细阅读本招股说明书和适用的招股说明书。
我们可能通过一个或多个承销商、经销商和代理商或直接向购买者出售本招股说明书中描述的证券,或通过这些方法的组合出售。如果有任何承销商、经销商或代理商参与出售任何证券,则他们的名称及他们之间的任何适用的购买价格、费用、委托或折扣安排将在适用的招股说明书中注明或可以从所列信息计算出来。有关更多信息,请参见本招股说明书中的“关于本招股说明书”和“分销计划”部分。
投资 投资我们的证券涉及风险。请参阅本招股说明书第4页和适用招股补充说明书中任何类似章节中与您投资我们的证券前应考虑的因素相关的内容。 “风险因素” 在本招股说明书第4页和任何类似部分以及适用招股说明书补充中所包括的有关您在投资本公司证券之前应考虑的因素。
The aggregate market value of our outstanding common stock held by non-affiliates is $5,659,238.18 based on 10,415,500 shares of outstanding common stock, of which 5,555,282 are held by affiliates, and a per share price of $1.42 based on the closing sale price of our common stock on July 22, 2024. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell our common stock in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75,000,000. We have not offered any securities pursuant to General Instruction I.B.6. of Form S-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus.
Our common stock is listed on The Nasdaq Capital Market under the symbol “SRM”.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The date of this prospectus is September 19, 2024.
TABLE OF CONTENTS
i |
This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission, or the SEC, using a “shelf” registration process. By using a shelf registration statement, we may sell securities from time to time and in one or more offerings up to a total dollar amount of $25 million as described in this prospectus. Each time that we offer and sell securities, we will provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold and the specific terms of that offering. The prospectus supplement may also add, update or change information contained in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you should rely on the prospectus supplement. Before purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement, together with the additional information described under the heading “Where You Can Find More Information; Incorporation by Reference.”
We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is accurate as of the date on its respective cover, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates.
When we refer to “SRM,” “we,” “our,” “us” and the “Company” in this prospectus, we mean SRM Entertainment, Inc., and its consolidated subsidiary unless otherwise specified. When we refer to “you,” we mean the holders of the applicable series of securities.
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
Available Information
The SEC maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is http://www.sec.gov.
Our website address is https://srmentertainment.com/. The information on our website, however, is not, and should not be deemed to be, a part of this prospectus.
This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Forms of the documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through the SEC’s website, as provided above.
Incorporation by Reference
The SEC’s rules allow us to “incorporate by reference” information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus modifies or replaces that statement.
We incorporate by reference our documents listed below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, which we refer to as the “Exchange Act” in this prospectus, between the date of this prospectus and the termination of the offering of the securities described in this prospectus. We are not, however, incorporating by reference any documents or portions thereof, whether specifically listed below or filed in the future, that are not deemed “filed” with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K or related exhibits furnished pursuant to Item 9.01 of Form 8-K.
1 |
This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC:
● | Our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024; |
● | Our Quarterly Report on Form 10-Q for the period ended March 31, 2024, filed with the SEC on May 10, 2024 and for the period ended June 30, 2024, filed with the SEC on August 12, 2024; |
● | Our Current Reports on Form 8-K filed with the SEC on September 6, 2024. |
● | The description of our common stock, par value $0.0001 per share (the “Common Stock”) contained in our Registration Statement on Form 8-A, filed with the SEC on August 2, 2023, as updated by “Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934” filed as Exhibit 4.3 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and any amendment or report filed for the purpose of updating such description. |
All reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.
You may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following address:
1061 E. Indiantown Rd., Ste. 110
Jupiter, FL 33477
Telephone: 407-230-8100
Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus and any accompanying prospectus supplement.
2 |
General Overview
SRM Entertainment, Inc. (“SRM Inc”) is a Nevada corporation and was incorporated on April 22, 2022. SRM. Entertainment Limited (“SRM Ltd”), is a limited company incorporated in the Hong Kong, now a Special Administrative Region of the People’s Republic of China, on January 23, 1981 and formerly owned by Jupiter Wellness, Inc.. Effective August 14, 2023, SRM Inc acquired SRM Ltd. The acquisition of SRM Ltd by SRM Inc has been accounted for as a Reverse Acquisition (see Basis of Presentation below). The combined SRM Inc and SRM Ltd are collectively referred to as the Company or SRM.
On December 9, 2022, we entered into a stock exchange agreement (the “Exchange Agreement”) with Jupiter Wellness, Inc. (“Jupiter”) to govern the separation of our business from Jupiter. On May 26, 2023, we amended and restated the Exchange Agreement (the “Share Exchange”) to include additional information regarding the distribution and the separation of our business from Jupiter. The separation as set forth in the Share Exchange with Jupiter closed August 14, 2023. Pursuant to the Share Exchange, on May 31, 2023, we issued 6,500,000 shares of our common stock (representing 79.3% of our outstanding shares of common stock) to Jupiter in exchange for 2 ordinary shares of SRM Ltd (representing all of the issued and outstanding ordinary shares of SRM Ltd). As of March 20, 2024, Jupiter owns 35% shares of our common stock.
Basis of Presentation
The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). The acquisition of SRM Ltd and SRM Inc occurred on August 14, 2023. The financial statements are prepared using Reverse Acquisition Accounting and as such, for legal purposes SRM Inc was the acquiring company and for GAAP accounting, SRM Ltd was the acquiring company. Therefore, the financial statements are presented using the historical financial statements of SRM Ltd.
Business
The Company is a trusted toy and souvenir designer and developer, selling into the world’s largest theme parks and entertainment venues.
Our business is built on the principle that almost everyone is a fan of something and the evolution of pop culture is leading to increasing opportunities for fan loyalty. We create whimsical, fun and unique products that enable fans to express their affinity for their favorite “something”-whether it is a movie, TV show, favorite celebrity, or favorite restaurant. We infuse our distinct designs and aesthetic sensibility into a wide variety of product categories, including figures, plush, accessories, apparel, and homewares. With our unique style, expertise in pop culture, broad product distribution and highly accessible price points, we have developed a passionate following for our products that has underpinned our growth. We believe we sit at the nexus of pop culture-content providers value us for our broad network of retail customers, retailers value us for our portfolio of pop culture products and pop culture insights, and consumers value us for our distinct, stylized products and the content they represent.
Pop culture pervades modern life and almost everyone is a fan of something. Today, more quality content is available and technology innovation has made content accessible anytime, anywhere. As a result, the breadth and depth of pop culture fandom resembles, and in many cases exceeds, the type of fandom previously associated only with sports. Everyday interactions at home, work or with friends are increasingly influenced by pop culture.
We have invested strategically in our relationships with key constituents in pop culture. Content providers value us for our broad network of retail customers and retailers value us for our pop culture products, pop culture insights and ability to drive consumer traffic. Consumers, who value us for our distinct, stylized products, remain at the center of everything we do.
3 |
On September 3, 2024, the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Suretone Entertainment, Inc. (“Suretone” or “Seller”) pursuant to which the Company agreed to acquire certain assets related to the movie with the title The Kid (directed by Vincent D’Onofrio) from the Seller, for an aggregate purchase price of $3,000,000 (the “Purchase Price”). Jordan Schur, the owner and Chief Executive Officer of Suretone, is a board member and President of Safety Shot, Inc. (“Safety Shot”). Prior to the transaction, Safety Shot held 34.27% of the Company’s common stock.
In consideration for the acquired assets, the Buyer paid the Purchase Price by: (i) paying $250,000 in cash on September 3, 2024; (ii) issuing 1,500,000 restricted shares of the Company’s common stock, par value $0.0001 per share (valued at $0.8333 per share); and (iii) issuing a secured promissory note in the original amount of $1,500,000 (the “Secured Note”).
Content Providers: We have licensing relationships with many established content providers, and our products appear in venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Cedar Fair, Herschend Family Entertainment and Merlin Entertainment. We currently have licenses with Smurfs, The ICEE Company and Zoonicorn LLC, from which we can create multiple products based on each character within. Content providers trust us to design, create and manufacture unique, stylized extensions of their intellectual property that extend the relevance of their content with consumers through ongoing engagement, helping to maximize the lifetime value of their content.
Consumers: Fans are increasingly looking for ways to express their affinity for and engage with their favorite pop culture content. Over time, many of our consumers evolve from occasional buyers to more frequent purchasers, whom we categorize as enthusiasts or collectors. We create innovative products to appeal to a broad array of fans across consumer demographic groups-men, women, boys and girls-not a single, narrow demographic. We currently offer an array of products that sell across several categories. Our products are generally priced between $2.50 and $50.00, which allows our diverse consumer base to express their fandom frequently and impulsively. We continue to introduce innovative products designed to facilitate fan engagement at different price points and styles.
We have developed a nimble and low-fixed cost production model. The strength of our management team and relationships with content providers, retailers and third-party manufacturers allows us to move from product concept to a new product tactfully. As a result, we can dynamically manage our business to balance current content releases and pop culture trends with timeless content based on classic movies, such as Harry Potter or Star Wars. This has allowed us to deliver significant growth while lessening our dependence on individual content releases.
Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K we file after the date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.
SPECIAL NOTICE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements that involve risks and uncertainties, principally in the sections entitled “Risk Factors.” All statements other than statements of historical fact contained in this prospectus, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under “Risk Factors” or elsewhere in this prospectus, which may cause our or our industry’s actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
4 |
Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from what is expressed in or suggested by the forward-looking statements.
Forward-looking statements speak only as of the date they are made. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement.
The following description of our capital stock is not complete and may not contain all the information you should consider before investing in our capital stock. This description is summarized from, and qualified in its entirety by reference to, our Articles of Incorporation, as amended and Bylaws, as amended which have been publicly filed with the SEC. See “Where You Can Find More Information; Incorporation by Reference.”
Description of Common Stock
Our authorized capital stock consists of 100,000,000 shares of Common Stock, and 10,000,000 shares of preferred stock, par value $0.0001 per share (the “Preferred Stock”), of which 1,000,000 shares are designated as Series A Preferred Stock. As of September 4, 2024, there were 10,415,500 shares of Common Stock issued and outstanding and no shares of preferred stock outstanding.
Dividend Rights
Subject to preferences that may apply to any shares of Preferred Stock outstanding at the time, the holders of our Common Stock may receive dividends out of funds legally available if our board of directors (the “Board”), in its discretion, determines to issue dividends and then only at the times and in the amounts that our Board may determine. The Company did not declare or pay any dividends for the year ended December 31, 2023.
Voting Rights
Each stockholder is entitled to one vote for each share of Common Stock held by such stockholder. The Common Stock shares do not contain cumulative voting rights.
No Preemptive or Similar Rights
Our Common Stock is not entitled to preemptive or conversion rights or other subscription rights, and is not subject to redemption or sinking fund provisions.
5 |
Right to Receive Liquidation Distributions
Holders of common stock are entitled to dividends when, and if, declared by the Board out of funds legally available therefore; and then, only after all preferential dividends have been paid on any outstanding Preferred Stock.
Transfer Agent and Registrar
The Company’s transfer agent is ClearTrust Transfer, LLC with an address of 16540 Pointe Village Drive, Suite 210, Lutz, FL 33558 and a phone number of (813) 235-4490.
The Common Stock is listed on the Nasdaq Capital Market under the trading symbol “SRM”.
Anti-takeover Effects of Our Articles of Incorporation and By-laws
The holders of our Common Stock do not have cumulative voting rights in the election of our directors, which makes it more difficult for minority stockholders to be represented on the Board. Our articles of incorporation allow our Board to issue additional shares of our Common Stock and new series of preferred stock without further approval of our stockholders. The existence of authorized but unissued shares of Common Stock and preferred stock could render more difficult or discourage an attempt to obtain control of our company by means of a proxy contest, tender offer, merger, or otherwise.
Anti-Takeover Provisions
Business Combinations
The “business combination” provisions of Sections 78.411 to 78.444, inclusive, of the Nevada Revised Statutes, or NRS, generally prohibit a Nevada corporation with at least 200 stockholders of record, a “resident domestic corporation,” from engaging in various “combination” transactions with any “interested stockholder” unless certain conditions are met or the corporation has elected in its articles of incorporation to not be subject to these provisions. We have not elected to opt out of these provisions and if we meet the definition of resident domestic corporation, now or in the future, our company will be subject to these provisions.
A “combination” is generally defined to include (a) a merger or consolidation of the resident domestic corporation or any subsidiary of the resident domestic corporation with the interested stockholder or affiliate or associate of the interested stockholder; (b) any sale, lease, exchange, mortgage, pledge, transfer, or other disposition, in one transaction or a series of transactions, by the resident domestic corporation or any subsidiary of the resident domestic corporation to or with the interested stockholder or affiliate or associate of the interested stockholder having: (i) an aggregate market value equal to 5% or more of the aggregate market value of the assets of the resident domestic corporation, (ii) an aggregate market value equal to 5% or more of the aggregate market value of all outstanding shares of the resident domestic corporation, or (iii) 10% or more of the earning power or net income of the resident domestic corporation; (c) the issuance or transfer in one transaction or series of transactions of shares of the resident domestic corporation or any subsidiary of the resident domestic corporation having an aggregate market value equal to 5% or more of the resident domestic corporation to the interested stockholder or affiliate or associate of the interested stockholder; and (d) certain other transactions with an interested stockholder or affiliate or associate of the interested stockholder.
An “interested stockholder” is generally defined as a person who, together with affiliates and associates, owns (or within two years, did own) 10% or more of a corporation’s voting stock. An “affiliate” of the interested stockholder is any person that directly or indirectly through one or more intermediaries is controlled by or is under common control with the interested stockholder. An “associate” of an interested stockholder is any (a) corporation or organization of which the interested stockholder is an officer or partner or is directly or indirectly the beneficial owner of 10% or more of any class of voting shares of such corporation or organization; (b) trust or other estate in which the interested stockholder has a substantial beneficial interest or as to which the interested stockholder serves as trustee or in a similar fiduciary capacity; or (c) relative or spouse of the interested stockholder, or any relative of the spouse of the interested stockholder, who has the same home as the interested stockholder.
6 |
If applicable, the prohibition is for a period of two years after the date of the transaction in which the person became an interested stockholder, unless such transaction is approved by the board of directors prior to the date the interested stockholder obtained such status; or the combination is approved by the board of directors and thereafter is approved at a meeting of the stockholders by the affirmative vote of stockholders representing at least 60% of the outstanding voting power held by disinterested stockholders; and extends beyond the expiration of the two-year period, unless (a) the combination was approved by the board of directors prior to the person becoming an interested stockholder; (b) the transaction by which the person first became an interested stockholder was approved by the board of directors before the person became an interested stockholder; (c) the transaction is approved by the affirmative vote of a majority of the voting power held by disinterested stockholders at a meeting called for that purpose no earlier than two years after the date the person first became an interested stockholder; or (d) if the consideration to be paid to all stockholders other than the interested stockholder is, generally, at least equal to the highest of: (i) the highest price per share paid by the interested stockholder within the three years immediately preceding the date of the announcement of the combination or in the transaction in which it became an interested stockholder, whichever is higher, plus compounded interest and less dividends paid, (ii) the market value per share of common shares on the date of announcement of the combination and the date the interested stockholder acquired the shares, whichever is higher, plus compounded interest and less dividends paid, or (iii) for holders of preferred stock, the highest liquidation value of the preferred stock, plus accrued dividends, if not included in the liquidation value. With respect to (i) and (ii) above, the interest is compounded at the rate for one-year United States Treasury obligations from time to time in effect.
Applicability of the Nevada business combination statute would discourage parties interested in taking control of our company if they cannot obtain the approval of our Board. These provisions could prohibit or delay a merger or other takeover or change in control attempt and, accordingly, may discourage attempts to acquire our company even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price.
Control Share Acquisitions
The “control share” provisions of Sections 78.378 to 78.3793, inclusive, of the NRS, apply to “issuing corporations” that are Nevada corporations with at least 200 stockholders of record, including at least 100 stockholders of record who are Nevada residents, and that conduct business directly or indirectly in Nevada, unless the corporation has elected to not be subject to these provisions.
The control share statute prohibits an acquirer of shares of an issuing corporation, under certain circumstances, from voting its shares of a corporation’s stock after crossing certain ownership threshold percentages, unless the acquirer obtains approval of the target corporation’s disinterested stockholders. The statute specifies three thresholds: (a) one-fifth or more but less than one-third, (b) one-third but less than a majority, and (c) a majority or more, of the outstanding voting power. Generally, once a person acquires shares in excess of any of the thresholds, those shares and any additional shares acquired within 90 days thereof become “control shares” and such control shares are deprived of the right to vote until disinterested stockholders restore the right. These provisions also provide that if control shares are accorded full voting rights and the acquiring person has acquired a majority or more of all voting power, all other stockholders who do not vote in favor of authorizing voting rights to the control shares are entitled to demand payment for the fair value of their shares in accordance with statutory procedures established for dissenters’ rights.
A corporation may elect to not be governed by, or “opt out” of, the control shares provisions by making an election in its articles of incorporation or bylaws, provided that the opt-out election must be in place on the 10th day following the date an acquiring person has acquired a controlling interest, that is, crossing any of the three thresholds described above. We have not opted out of these provisions and will be subject to the control share provisions of the NRS if we meet the definition of an issuing corporation upon an acquiring person acquiring a controlling interest unless we later opt out of these provisions and the opt out is in effect on the 10th day following such occurrence.
The effect of the Nevada control share statute is that the acquiring person, and those acting in association with the acquiring person, will obtain only such voting rights in the control shares as are conferred by a resolution of the stockholders at an annual or special meeting. The Nevada control share law, if applicable, could have the effect of discouraging takeovers of our company.
7 |
DESCRIPTION OF DEBT SECURITIES
General
The debt securities that we may offer by this prospectus consist of notes, debentures, or other evidences of indebtedness. The debt securities may constitute either senior or subordinated debt securities, and in either case may be either secured or unsecured. Any debt securities that we offer and sell will be our direct obligations. Debt securities may be issued in one or more series. All debt securities of any one series need not be issued at the same time, and unless otherwise provided, a series of debt securities may be reopened, with the required consent of the holders of outstanding debt securities, for issuance of additional debt securities of that series or to establish additional terms of that series of debt securities (with such additional terms applicable only to unissued or additional debt securities of that series). The form of indenture has been filed as an exhibit to the registration statement of which this prospectus is a part and is subject to any amendments or supplements that we may enter into with the trustee(s), however, we may issue debt securities not subject to the indenture provided such terms of debt securities are not otherwise required to be set forth in the indenture. The material terms of the indenture are summarized below and we refer you to the indenture for a detailed description of these material terms. Additional or different provisions that are applicable to a particular series of debt securities will, if material, be described in a prospectus supplement relating to the offering of debt securities of that series. These provisions may include, among other things and to the extent applicable, the following:
● | the title of the debt securities, including, as applicable, whether the debt securities will be issued as senior debt securities, senior subordinated debt securities or subordinated debt securities, any subordination provisions particular to the series of debt securities; |
● | any limit on the aggregate principal amount of the debt securities; |
● | whether the debt securities are senior debt securities or subordinated debt securities and applicable subordination provisions, if any; |
● | whether the debt securities will be secured or unsecured; |
● | if other than 100% of the aggregate principal amount, the percentage of the aggregate principal amount at which we will sell the debt securities, such as an original issuance discount; |
● | the date or dates, whether fixed or extendable, on which the principal of the debt securities will be payable; |
● | the rate or rates, which may be fixed or variable, at which the debt securities will bear interest, if any, the date or dates from which any such interest will accrue, the interest payment dates on which we will pay any such interest, the basis upon which interest will be calculated if other than that of a 360-day year consisting of twelve 30-day months, and, in the case of registered securities, the record dates for the determination of holders to whom interest is payable; |
● | the place or places where the principal of and any premium or interest on the debt securities will be payable and where the debt securities may be surrendered for conversion or exchange; |
● | whether we may, at our option, redeem the debt securities, and if so, the price or prices at which, the period or periods within which, and the terms and conditions upon which, we may redeem the debt securities, in whole or in part, pursuant to any sinking fund or otherwise; |
● | if other than 100% of the aggregate principal amount thereof, the portion of the principal amount of the debt securities which will be payable upon declaration of acceleration of the maturity date thereof or provable in bankruptcy, or, if applicable, which is convertible or exchangeable; |
8 |
● | any obligation we may have to redeem, purchase or repay the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities, and the price or prices at which, the currency in which and the period or periods within which, and the terms and conditions upon which, the debt securities will be redeemed, purchased or repaid, in whole or in part, pursuant to any such obligation, and any provision for the remarketing of the debt securities; |
● | the issuance of debt securities as registered securities or unregistered securities or both, and the rights of the holders of the debt securities to exchange unregistered securities for registered securities, or vice versa, and the circumstances under which any such exchanges, if permitted, may be made; |
● | the denominations, which may be in United States Dollars or in any foreign currency, in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof; |
● | whether the debt securities will be issued in the form of certificated debt securities, and if so, the form of the debt securities (or forms thereof if unregistered and registered securities are issuable in that series), including the legends required by law or as we deem necessary or appropriate, the form of any coupons or temporary global security which may be issued and the forms of any other certificates which may be required under the indenture or which we may require in connection with the offering, sale, delivery or exchange of the debt securities; |
● | if other than United States Dollars, the currency or currencies in which payments of principal, interest and other amounts payable with respect to the debt securities will be denominated, payable, redeemable or repurchasable, as the case may be; |
● | whether the debt securities may be issuable in tranches; |
● | the obligations, if any, we may have to permit the conversion or exchange of the debt securities into Common Stock, preferred stock or other capital stock or property, or a combination thereof, and the terms and conditions upon which such conversion or exchange will be effected (including conversion price or exchange ratio), and any limitations on the ownership or transferability of the securities or property into which the debt securities may be converted or exchanged; |
● | if other than the trustee under the indenture, any trustees, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the debt securities; |
● | any deletions from, modifications of or additions to the events of default with respect to the debt securities or the right of the Trustee or the holders of the debt securities in connection with events of default; |
● | any deletions from, modifications of or additions to the covenants with respect to the debt securities; |
● | if the amount of payments of principal of, and make-whole amount, if any, and interest on the debt securities may be determined with reference to an index, the manner in which such amount will be determined; |
● | whether the debt securities will be issued in whole or in part in the global form of one or more debt securities and, if so, the depositary for such debt securities, the circumstances under which any such debt security may be exchanged for debt securities registered in the name of, and under which any transfer of debt securities may be registered in the name of, any person other than such depositary or its nominee, and any other provisions regarding such debt securities; |
● | whether, under what circumstances and the currency in which, we will pay additional amounts on the debt securities to any holder of the debt securities who is not a United States person in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem such debt securities rather than pay such additional amounts, and the terms of any such option; |
● | whether the debt securities will be secured by any collateral and, if so, a general description of the collateral and the terms of any related security, pledge or other agreements; |
9 |
● | the persons to whom any interest on the debt securities will be payable, if other than the registered holders thereof on the regular record date therefor; and |
● | any other material terms or conditions upon which the debt securities will be issued. |
Unless otherwise indicated in the applicable prospectus supplement, we will issue debt securities in fully registered form without coupons and in denominations of $1,000 and in integral multiples of $1,000, and interest will be computed on the basis of a 360-day year of twelve 30-day months. If any interest payment date or the maturity date falls on a day that is not a business day, then the payment will be made on the next business day without additional interest and with the same effect as if it were made on the originally scheduled date. “Business day” means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York, and on which the trustee and commercial banks are open for business in New York, New York.
Unless we inform you otherwise in a prospectus supplement, each series of our senior debt securities will rank equally in right of payment with all of our other unsubordinated debt. The subordinated debt securities will rank junior in right of payment and be subordinate to all of our unsubordinated debt.
Unless otherwise indicated in the applicable prospectus supplement, the trustee will act as paying agent and registrar for the debt securities under the indenture. We may act as paying agent under the indenture.
The prospectus supplement will contain a description of United States federal income tax consequences relating to the debt securities, to the extent applicable.
Covenants
The applicable prospectus supplement will describe any covenants, such as restrictive covenants restricting us or our subsidiaries, if any, from incurring, issuing, assuming or guarantying any indebtedness or restricting us or our subsidiaries, if any, from paying dividends or acquiring any of our or its capital stock.
Consolidation, Merger and Transfer of Assets
The indenture permits a consolidation or merger between us and another entity and/or the sale, conveyance or lease by us of all or substantially all of our property and assets, provided that:
● | the resulting or acquiring entity, if other than us, is organized and existing under the laws of a United States jurisdiction and assumes all of our responsibilities and liabilities under the indenture, including the payment of all amounts due on the debt securities and performance of the covenants in the indenture; |
● | immediately after the transaction, and giving effect to the transaction, no event of default under the indenture exists; and |
● | we have delivered to the trustee an officers’ certificate stating that the transaction and, if a supplemental indenture is required in connection with the transaction, the supplemental indenture comply with the indenture and that all conditions precedent to the transaction contained in the indenture have been satisfied. |
If we consolidate or merge with or into any other entity, or sell or lease all or substantially all of our assets in compliance with the terms and conditions of the indenture, the resulting or acquiring entity will be substituted for us in the indenture and the debt securities with the same effect as if it had been an original party to the indenture and the debt securities. As a result, such successor entity may exercise our rights and powers under the indenture and the debt securities, in our name and, except in the case of a lease, we will be released from all our liabilities and obligations under the indenture and under the debt securities.
Notwithstanding the foregoing, we may transfer all of our property and assets to another entity if, immediately after giving effect to the transfer, such entity is our wholly owned subsidiary. The term “wholly owned subsidiary” means any subsidiary in which we and/or our other wholly owned subsidiaries, if any, own all of the outstanding capital stock.
10 |
Modification and Waiver
Under the indenture, some of our rights and obligations and some of the rights of the holders of the debt securities may be modified or amended with the consent of the holders of not less than a majority in aggregate principal amount of the outstanding debt securities affected by the modification or amendment. However, the following modifications and amendments will not be effective against any holder without its consent:
● | a change in the stated maturity date of any payment of principal or interest; |
● | a reduction in the principal amount of or interest on any debt securities; |
● | an alteration or impairment of any right to convert at the rate or upon the terms provided in the indenture; |
● | a change in the currency in which any payment on the debt securities is payable; |
● | an impairment of a holder’s right to sue us for the enforcement of payments due on the debt securities; or |
● | a reduction in the percentage of outstanding debt securities required to consent to a modification or amendment of the indenture or required to consent to a waiver of compliance with certain provisions of the indenture or certain defaults under the indenture. |
Under the indenture, the holders of not less than a majority in aggregate principal amount of the outstanding debt securities may, on behalf of all holders of the debt securities:
● | waive compliance by us with certain restrictive provisions of the indenture; and |
● | waive any past default under the indenture in accordance with the applicable provisions of the indenture, except a default in the payment of the principal of or interest on any series of debt securities. |
Events of Default
Unless we indicate otherwise in the applicable prospectus supplement, “event of default” under the indenture will mean, with respect to any series of debt securities, any of the following:
● | failure to pay interest on any debt security for 30 days after the payment is due; |
● | failure to pay the principal of any debt security when due, either at maturity, upon redemption, by declaration or otherwise; |
● | failure on our part to observe or perform any other covenant or agreement in the indenture that applies to the debt securities for 90 days after we have received written notice of the failure to perform in the manner specified in the indenture; and |
● | certain events of bankruptcy, insolvency or reorganization. |
Remedies Upon an Event of Default
If an event of default occurs and continues, the trustee or the holders of not less than 25% in aggregate principal amount of the outstanding debt securities of such series may declare the entire principal of all the debt securities to be due and payable immediately, except that, if the event of default is caused by certain events in bankruptcy, insolvency or reorganization, the entire principal of all of the debt securities of such series will become due and payable immediately without any act on the part of the trustee or holders of the debt securities. If such a declaration occurs, the holders of a majority of the aggregate principal amount of the outstanding debt securities of such series can, subject to conditions, rescind the declaration.
11 |
The indenture requires us to furnish to the trustee not less often than annually, a certificate from our principal executive officer, principal financial officer or principal accounting officer, as the case may be, as to such officer’s knowledge of our compliance with all conditions and covenants under the indenture. The trustee may withhold notice to the holders of debt securities of any default, except defaults in the payment of principal of or interest on any debt securities if the trustee in good faith determines that the withholding of notice is in the best interests of the holders. For purposes of this paragraph, “default” means any event which is, or after notice or lapse of time or both would become, an event of default under the indenture.
The trustee is not obligated to exercise any of its rights or powers under the indenture at the request, order or direction of any holders of debt securities, unless the holders offer the trustee satisfactory security or indemnity. If satisfactory security or indemnity is provided, then, subject to other rights of the trustee, the holders of a majority in aggregate principal amount of the outstanding debt securities may direct the time, method and place of:
● | conducting any proceeding for any remedy available to the trustee; or |
● | exercising any trust or power conferred upon the trustee. |
The holder of a debt security will have the right to begin any proceeding with respect to the indenture or for any remedy only if:
● | the holder has previously given the trustee written notice of a continuing event of default; |
● | the holders of not less than a majority in aggregate principal amount of the outstanding debt securities have made a written request of, and offered reasonable indemnity to, the trustee to begin such proceeding; |
● | the trustee has not started such proceeding within 60 days after receiving the request; and |
● | no direction inconsistent with such written request has been given to the trustee under the indenture. |
However, the holder of any debt security will have an absolute right to receive payment of principal of and interest on the debt security when due and to institute suit to enforce this payment.
Satisfaction and Discharge; Defeasance
Satisfaction and Discharge of Indenture. Unless otherwise indicated in the applicable prospectus supplement, if at any time:
● | we have paid the principal of and interest on all the debt securities of any series, except for debt securities which have been destroyed, lost or stolen and which have been replaced or paid in accordance with the indenture, as and when the same shall have become due and payable; or |
● | we have delivered to the trustee for cancellation all debt securities of any series theretofore authenticated, except for debt securities of such series which have been destroyed, lost or stolen and which have been replaced or paid as provided in the indenture; or |
● | all the debt securities of such series not theretofore delivered to the trustee for cancellation have become due and payable, or are by their terms are to become due and payable within one year or are to be called for redemption within one year, and we have deposited with the trustee, in trust, sufficient money or government obligations, or a combination thereof, to pay the principal, any interest and any other sums due on the debt securities, on the dates the payments are due or become due under the indenture and the terms of the debt securities, |
12 |
then the indenture shall cease to be of further effect with respect to the debt securities of such series, except for:
● | rights of registration of transfer and exchange, and our right of optional redemption; |
● | substitution of mutilated, defaced, destroyed, lost or stolen debt securities; |
● | rights of holders to receive payments of principal thereof and interest thereon upon the original stated due dates therefor (but not upon acceleration) and remaining rights of the holders to receive mandatory sinking fund payments, if any; |
● | the rights, obligations and immunities of the trustee under the indenture; and |
● | the rights of the holders of such series of debt securities as beneficiaries thereof with respect to the property so deposited with the trustee payable to all or any of them. |
Defeasance and Covenant Defeasance. Unless otherwise indicated in the applicable prospectus supplement, we may elect with respect to any debt securities of any series either:
● | to defease and be discharged from all of our obligations with respect to such debt securities (“defeasance”), with certain exceptions described below; or |
● | to be released from our obligations with respect to such debt securities under such covenants as may be specified in the applicable prospectus supplement, and any omission to comply with those obligations will not constitute a default or an event of default with respect to such debt securities (“covenant defeasance”). |
We must comply with the following conditions before the defeasance or covenant defeasance can be effected:
● | we must irrevocably deposit with the indenture trustee or other qualifying trustee, under the terms of an irrevocable trust agreement in form and substance satisfactory to the trustee, trust funds in trust solely for the benefit of the holders of such debt securities, sufficient money or government obligations, or a combination thereof, to pay the principal, any interest and any other sums on the due dates for those payments; and |
● | we must deliver to the trustee an opinion of counsel to the effect that the holders of such debt securities will not recognize income, gain or loss for federal income tax purposes as a result of defeasance or covenant defeasance, as the case may be, to be effected with respect to such debt securities and will be subject to federal income tax on the same amount, in the same manner and at the same times as would be the case if such defeasance or covenant defeasance, as the case may be, had not occurred. |
In connection with defeasance, any irrevocable trust agreement contemplated by the indenture must include, among other things, provision for:
● | payment of the principal of and interest on such debt securities, if any, appertaining thereto when due (by redemption, sinking fund payments or otherwise); |
● | the payment of the expenses of the trustee incurred or to be incurred in connection with carrying out such trust provisions; |
● | rights of registration, transfer, substitution and exchange of such debt securities in accordance with the terms stated in the indenture; and |
● | continuation of the rights, obligations and immunities of the trustee as against the holders of such debt securities as stated in the indenture. |
The accompanying prospectus supplement may further describe any provisions permitting or restricting defeasance or covenant defeasance with respect to the debt securities of a particular series.
13 |
Global Securities
Unless otherwise indicated in the applicable prospectus supplement, each debt security offered by this prospectus will be issued in the form of one or more global debt securities representing all or part of that series of debt securities. This means that we will not issue certificates for that series of debt securities to the holders. Instead, a global debt security representing that series will be deposited with, or on behalf of, a securities depositary and registered in the name of the depositary or a nominee of the depositary. Any such depositary must be a clearing agency registered under the Exchange Act. We will describe the specific terms of the depositary arrangement with respect to a series of debt securities to be represented by a global security in the applicable prospectus supplement.
Notices
We will give notices to holders of the debt securities by mail at the addresses listed in the security register. In the case of notice in respect of unregistered securities or coupon securities, we may give notice by publication in a newspaper of general circulation in New York, New York.
Governing Law
The particular terms of a series of debt securities will be described in a prospectus supplement relating to such series of debt securities. Any indentures will be subject to and governed by the Trust Indenture Act of 1939, as amended, and may be supplemented or amended from time to time following their execution. Unless otherwise stated in the applicable prospectus supplement, we will not be limited in the amount of debt securities that we may issue, and neither the senior debt securities nor the subordinated debt securities will be secured by any of our property or assets. Thus, by owning debt securities, you are one of our unsecured creditors.
Regarding the Trustee
From time to time, we may maintain deposit accounts and conduct other banking transactions with the trustee to be appointed under the indenture or its affiliates in the ordinary course of business.
We may offer to sell warrants from time to time. If we do so, we will describe the specific terms of the warrants in a prospectus supplement. In particular, we may issue warrants for the purchase of Common Stock, preferred stock and/or debt securities in one or more series. We may also issue warrants independently or together with other securities and the warrants may be attached to or separate from those securities.
We will evidence each series of warrants by warrant certificates that we will issue under a separate agreement. We will enter into the warrant agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants.
14 |
We will describe in the applicable prospectus supplement the terms of the series of warrants, including:
● | the offering price and aggregate number of warrants offered; |
● | the currency for which the warrants may be purchased; |
● | if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; |
● | if applicable, the date on and after which the warrants and the related securities will be separately transferable; |
● | in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise; |
● | in the case of warrants to purchase Common Stock or preferred stock, the number of shares of Common Stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |
● | the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants; |
● | the terms of any rights to redeem or call the warrants; |
● | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; |
● | the dates on which the right to exercise the warrants will commence and expire; |
● | the manner in which the warrant agreement and warrants may be modified; |
● | certain United States federal income tax consequences of holding or exercising the warrants; |
● | the terms of the securities issuable upon exercise of the warrants; and |
● | any other specific material terms, preferences, rights or limitations of or restrictions on the warrants. |
Holders may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with other requested information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent.
Upon receipt of the required payment and the warrant certificate properly completed and duly executed at the office of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If a holder exercises fewer than all of the warrants represented by the warrant certificate, then we will issue a new warrant certificate for the remaining amount of warrants.
Holder will not have any of the rights of the holders of the securities purchasable upon the exercise of warrants until you exercise them. Accordingly, holder will not be entitled to, among other things, vote or receive dividend payments or similar distributions on the securities you can purchase upon exercise of the warrants.
The information provided above is only a summary of the terms under which we may offer warrants for sale. Accordingly, investors must carefully review the applicable warrant agreement for more information about the specific terms and conditions of these warrants before investing in us. In addition, please carefully review the information provided in the applicable prospectus supplement, which contains additional information that is important for you to consider in evaluating an investment in our securities.
15 |
We may issue rights to our stockholders to purchase shares of our Common Stock or preferred stock described in this prospectus. We may offer rights separately or together with one or more additional rights, preferred stock, Common Stock, warrants or any combination of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent for any rights we offer will be set forth in the applicable prospectus supplement. The rights agent will act solely as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The following description sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The particular terms of the rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the rights so offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the rights, rights agreement or rights certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below will be deemed to have been superseded by that prospectus supplement. We encourage you to read the applicable rights agreement and rights certificate for additional information before you decide whether to purchase any of our rights.
The prospectus supplement relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:
● | the date of determining the stockholders entitled to the rights distribution; |
● | the aggregate number of shares of Common Stock, preferred stock or other securities purchasable upon exercise of the rights; |
● | the exercise price; |
● | the aggregate number of rights issued; |
● | whether the rights are transferrable and the date, if any, on and after which the rights may be separately transferred; |
● | the date on which the right to exercise the rights will commence, and the date on which the right to exercise the rights will expire; |
● | the method by which holders of rights will be entitled to exercise; |
● | the conditions to the completion of the offering; |
● | the withdrawal, termination and cancellation rights; |
● | whether there are any backstop or standby purchaser or purchasers and the terms of their commitment; |
● | whether stockholders are entitled to oversubscription right; |
● | any U.S. federal income tax considerations; and |
● | any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights. |
If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement. In connection with any rights offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering.
16 |
We may issue units consisting of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of units by unit certificates that we will issue under a separate agreement. We may enter into unit agreements with a unit agent. We will indicate the name and address of the unit agent in the applicable prospectus supplement relating to a particular series of units.
The following description, together with the additional information included in any applicable prospectus supplement, summarizes the general features of the units that we may offer under this prospectus. You should read any prospectus supplement and any free writing prospectus that we may authorize to be provided to you related to the series of units being offered, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements will contain additional important terms and provisions and we will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with the SEC, the form of each unit agreement relating to units offered under this prospectus.
If we offer any units, certain terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following, as applicable:
● | 单位系列的名称; |
● | 单独的组成证券的鉴别和描述; |
● | 单位的发行价格或价格; |
● | 单位单独转让的日期,如果有的话; |
● | 适用于单位的某些美国联邦所得税因素的讨论; |
● |
我们可能通过包销公开发行、协商交易、大宗交易或上述方法的组合,或通过经销商或交易商、代理商和/或直接向一个或多个购买者销售证券。证券可能在一个或多个交易中分拆出售:
● | 以固定价格或价格,可能会更改; |
● | 以当时出售时市场价格为基础的市场价格; |
● | 与这些现行市场价格有关的价格;或者 |
● | 协商价格。 |
每次我们卖出本招股说明书所涵盖的证券,我们将提供一份或多份招股说明书补充资料,其中将描述分销方法,并规定该证券的发行条件,包括证券的发行价格和我们的获利(如适用)。
本募股说明书提供的证券购买要约可以直接征求。代理可以被指定以不时地征求购买证券的要约。参与证券的发行或销售的任何代理将在募股说明书补充中进行披露。
17 |
如果在发行本募股说明书中所募集的证券的销售中使用了经销商,则经销商将作为本身出售这些证券。经销商可能会以不同的价格向公众转售证券,由经销商决定。
如果在本招股说明书的发售过程中使用承销商,将在发售时与承销商签订一份承销协议,并且任何承销商的名称将在承销商在发售证券给公众时所使用的招股说明书补充中提供。与发售证券相关的我们或者由承销商充当代理人购买证券的买方可能会以承销折扣或佣金的形式对承销商进行补偿。承销商可能将证券销售给或通过经销商,那些经销商可能会从承销商和/或购买者那里以折扣、让步或佣金的形式获得补偿,他们可能以代理人的身份行事。除非在招股说明书补充中另有说明,代理人将以最大努力的原则行事,并且经销商将以自营方式购买证券,然后按经销商确定的不同价格再次转售证券。
有关证券发行所支付给承销商、经销商或代理商的任何补偿,以及承销商向参与的经销商提供的任何折扣、优惠或佣金将在适用的招股说明书中提供。参与证券发行的承销商、经销商和代理商可能被视为《1933年证券法》及其修订案的含义中的承销商,他们所获得的折扣和佣金以及他们在转售证券时所获得的利润可能被视为承销折扣和佣金。我们可能会与承销商、经销商和代理商签订协议,对其在《证券法》下的民事责任进行赔偿,或者对他们可能需要支付的款项进行贡献,并对这些人支付某些费用。
任何普通股都将在纳斯达克资本市场上市,但任何其他证券可能会或可能不会在全国证券交易所上市。为了促进证券的发行,参与发行的某些人可能会进行稳定、维持或以其他方式影响证券价格的交易。这可能包括超额配售或卖空榜交易,即发行参与人出售的证券数量超过他们购买的证券数量。在这种情况下,这些人将通过在开放市场上购买或行使其超额配售选择权来偿还超额配售或开空仓位。此外,这些人可能通过在开放市场上竞标或购买证券或对经销商允许出售佣金进行罚款竞标来稳定或维持证券价格,如果他们出售的证券与稳定交易相关地回购,允许给予他们的销售佣金可以收回。这些交易的效果可能是在开放市场上稳定或维持证券的市场价格高于否则可能在开放市场上存在的价格水平。这些交易可以随时终止。
我们可能根据证券法第415(a)(4)条的规定,参与市场现有交易市场的安排。
此外,我们可能与第三方进行衍生交易,或在私下协商交易中向第三方出售未包含在本招股说明书中的证券。如果适用的招股说明书如此指示,在这些衍生品中,第三方可能会出售在本招股说明书和适用的招股说明书中包含的证券,包括在空头销售交易中。如果是这样,在进行这些销售或关闭与之相关的任何股票借贷开放方向之前,第三方可能会使用我们或其他人抵押或借入的证券来结算这些销售,并可能使用从我们收到的证券来结算这些衍生品与之相关的任何股票的开放借贷。进行此类销售交易的第三方将成为承销商,如未在本招股说明书中标明,将在适用的招股说明书中(或后期有效的修正案中)列明。此外,我们可能会以另一种方法向财务机构或其他第三方贷款或抵押证券,后者可以使用本招股说明书和适用的招股说明书进行空头销售。这样的金融机构或其他第三方可能会将其经济空头头寸转移给我们证券或与我们证券有关的其他证券的投资者,或与其他证券的同时发行相关联的证券。
我们不对上述交易可能对证券价格产生的任何影响的方向或程度作出任何陈述或预测。此外,我们不保证承销商会进行此类交易,也不保证一旦开始进行此类交易,就不会在没有通知的情况下终止。
18 |
在任何特定的发行中锁定的条款将在适用的代号说明书中描述。
为了遵守适用州证券法律,本招股书所提供的证券,如有必要,在这些司法辖区仅可通过已注册或持牌经纪商或经销商出售。另外,除非在适用州登记或符合销售资格或已获得豁免登记或资格要求并进行了遵守,证券可能无法在某些州出售。
承销商、经销商和代理商在一般业务活动中可能与我们进行交易或为我们提供服务,以获得报酬。
Lucosky Brookman LLP位于新泽西州伍德布里奇,将就此处所提供的证券的发行和销售相关的某些法律事项给予意见,代表SRm娱乐公司。我们或任何承销商、经销商或代理商可能还需要由我们在适用的招股说明书补充中指定的律师对其他法律事项给予意见。
截至2023年12月31日和2022年,我们的综合资产负债表,以及相关的综合损益表、股东权益(赤字)和现金流量表,已经由独立注册的会计师事务所M&k CPAS, PLLC进行了审计,其报告已作为参考并依赖于该公司的会计和审计专家意见。
19 |
1,711,477
普通股份的股票
SRM 娱乐,公司。
招股书补充资料
2024年10月21日